(Q53028980)

10 May 2018

title

B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas. (English)

1 reference

10 May 2018

author

Roberto N. Miranda

5

1 reference

10 May 2018

author name string

Shaoying Li

1

1 reference

10 May 2018

Adam C Seegmiller

2

1 reference

10 May 2018

Pei Lin

3

1 reference

10 May 2018

Xuan J Wang

4

1 reference

10 May 2018

Sharathkumar Bhagavathi

6

1 reference

10 May 2018

L Jeffrey Medeiros

7

1 reference

10 May 2018

publication date

8 August 2014

1 reference

10 May 2018

published in

Modern Pathology

1 reference

10 May 2018

volume

28

1 reference

10 May 2018

issue

2

1 reference

10 May 2018

page(s)

208-217

1 reference

10 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2014.95

exact match

0 references

cites work

Double-hit B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Widespread microRNA repression by Myc contributes to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Targeting MYC-Regulated miRNAs to Combat Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Advances in the understanding of MYC-induced lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

MYC/BCL2 double-hit high-grade B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Pathogenesis of human B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Expression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2014.95

Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype".

21 January 2018

1 reference

12 December 2020

BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma

1 reference

12 December 2020

Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation

1 reference

12 December 2020

High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis

1 reference

12 December 2020

[Detection of t (14; 18) translocation and bcl-2 amplification in diffuse large B-cell lymphoma]

1 reference

12 December 2020

Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis

1 reference

12 December 2020

10.1038/MODPATHOL.2014.95

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018